Bosch Packaging Technology presents its new data mining service, which has recently been added to the range of pharma services for solid dosage forms. The service is offered by the Bosch subsidiary Hüttlin. The aim is to evaluate existing machine data more effectively to identify and eliminate root causes.
Consistently high product quality is a critical factor in the pharmaceutical industry, since authorities such as the FDA and EMA have strict guidelines for process understanding, monitoring and validation.
Thanks to Bosch’s data mining tool, it is now possible to examine large amounts of data for the smallest effects using statistical methods. In general, the data from two production batches is already sufficient to draw first conclusions. The more data is available for evaluation over a longer period, the more details can be identified. All it takes is machine sensors, which already collect data on almost all historical machines, as well as the right tool to disclose the data.
The potential of this approach has already been demonstrated successfully in different customer projects. For instance, when a customer suddenly produced a “out of specification” (OOS) batch, the Bosch experts systematically got to the bottom of things. The recorded data showed that a particular valve was responsible for the deviation. However, the valve had been excluded beforehand since it was considered uncritical in terms of product quality. Thanks to the data analysis, deeper correlations and an undetected cascade of connections could be identified.
The Bosch division Robert Bosch Packaging Technology GmbH is one of the leading suppliers in the field of processing and packaging technology.